Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Pharmaceuticals

    Pharmaceuticals - Page 315

    Eli Lilly breast cancer drug wins expanded US approval

    Eli Lilly breast cancer drug wins expanded US approval

    Ruby Khatun Khatun28 Feb 2018 10:00 AM IST
    U.S. regulators have approved expanded the use of Eli Lilly and Co’s Verzenio breast cancer drug as an initial treatment for certain women with the...
    US patent court deals setback to Allergans Restasis strategy

    US patent court deals setback to Allergan's Restasis strategy

    Ruby Khatun Khatun28 Feb 2018 9:45 AM IST
    A U.S. administrative court said it has the authority to decide the validity of patents Allergan Plc transferred to a Native American tribe, dealing a...
    Judge rules against Pharma Bro on investor losses

    Judge rules against Pharma Bro on investor losses

    Ruby Khatun Khatun28 Feb 2018 9:30 AM IST
    NEW YORK: "Pharma Bro" Martin Shkreli was responsible for nearly $10.5 million in losses in a securities fraud scheme, a judge ruled Monday, a blow to...
    Lupin launches generic Axiron topical solution in US

    Lupin launches generic Axiron topical solution in US

    Ruby Khatun Khatun27 Feb 2018 12:30 PM IST
    New Delhi: Drug firm Lupin said it has launched its testosterone topical solution in the American market.The company has launched Testosterone Topical...
    Shantha Biotechnics receives WHO nod for cholera vaccine storage

    Shantha Biotechnics receives WHO nod for cholera vaccine storage

    Ruby Khatun Khatun27 Feb 2018 10:45 AM IST
    New Delhi: Sanofi Pasteur said its affiliate Shantha Biotechnics has received approval from the World Health Organization for storage of its oral...
    Aurobindo Pharma eyes Apotex European business

    Aurobindo Pharma eyes Apotex European business

    Ruby Khatun Khatun27 Feb 2018 10:15 AM IST
    New Delhi: Aurobindo Pharma is reported to have shown an interest to buy European business of Canadian drugmaker Apotex.According to industry sources,...
    KemPharms opioid painkiller gets FDA approval

    KemPharm's opioid painkiller gets FDA approval

    Ruby Khatun Khatun27 Feb 2018 9:30 AM IST
    KemPharm Inc said the U.S. Food and Drug Administration approved its opioid painkiller Apadaz for the short-term management of acute pain.The company...
    Dr Reddys gets EIR from USFDA for Srikakulam plant

    Dr Reddy's gets EIR from USFDA for Srikakulam plant

    Ruby Khatun Khatun26 Feb 2018 11:52 AM IST
    New Delhi: Pharma major Dr Reddy's Laboratories (DRL) said it has received the establishment inspection report (EIR) from the US Food and Drug...
    India, Uzbek region ink pharma pact

    India, Uzbek region ink pharma pact

    Ruby Khatun Khatun26 Feb 2018 10:15 AM IST
    New Delhi: The Andijan Region of Uzbekistan and India have inked an agreement for cooperation in the pharmaceutical industry.A joint statement...
    Merck to buy Viralytics for 394 million dollars

    Merck to buy Viralytics for 394 million dollars

    Ruby Khatun Khatun26 Feb 2018 10:00 AM IST
    U.S. drugmaker Merck & Co, already one of the leaders in the hot area of cancer immunotherapy, said it had agreed to buy Viralytics for 502...
    Daiichi Sankyo initiates phase 1 study of DS-1062 in patients with advanced NSCLC

    Daiichi Sankyo initiates phase 1 study of DS-1062 in patients with advanced NSCLC

    Ruby Khatun Khatun26 Feb 2018 9:45 AM IST
    TOKYO, BASKING RIDGE, N.J. and MUNICH: Daiichi Sankyo announced the first patient has been dosed in a phase 1 study assessing the safety and...
    EU panel recommends against nod for Puma Biotechs breast cancer drug

    EU panel recommends against nod for Puma Biotech's breast cancer drug

    Ruby Khatun Khatun26 Feb 2018 9:30 AM IST
    A European Medicines Agency (EMA) panel recommended against approving Puma Biotechnology’s lead breast cancer drug, an outcome the U.S drugmaker had...
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    FDC Ban: Avoid These Combinations of Paracetamol

    FDC Ban: Avoid These Combinations of Paracetamol

    Relief to Lupin: High court removes ban its diabetes drug Gluconorm P 30

    Relief to Lupin: High court removes ban its diabetes drug Gluconorm P 30

    Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

    Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok